Evolution of disease following alloSCT. (A) Evolution of patients who received a transplant with previous lymphoproliferative disease by status of malignancy at alloSCT. All patients had CID (n = 22). Two patients were alive in complete remission with mixed chimerism at last review. (B) Evolution of patients who received a transplant with no prior lymphoproliferative disease by status of IEI-related complication at alloSCT. Patients had CID (n = 36, light gray) or CGD (n = 20 patients, dark gray). Twelve patients were alive with mixed chimerism at last review, of whom 6 were in complete remission. Arrows and circles indicate living patients and mixed chimerism, respectively, at last review. The letter A indicates subsequent alloSCT performed 5, 7, and 10 months after the first alloSCT, respectively.